TGFB1 and neoplasm: This additional anti‐tumor function may arise from the production of immunostimulatory cytokines by activated TGF‐β CAR‐T cells,14 which could support not only the engineered CAR‐T cells but also endogenous tumor‐specific cytotoxic lymphocytes.